Lecap Asset Management Ltd. Grows Holdings in Colgate-Palmolive (NYSE:CL)

Lecap Asset Management Ltd. boosted its stake in Colgate-Palmolive (NYSE:CLFree Report) by 130.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,182 shares of the company’s stock after acquiring an additional 14,261 shares during the period. Lecap Asset Management Ltd.’s holdings in Colgate-Palmolive were worth $2,289,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $32,000. Hager Investment Management Services LLC acquired a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $36,000. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $53,000. Finally, Synergy Asset Management LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $49,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $85.60 on Friday. The company has a 50-day simple moving average of $90.78 and a 200 day simple moving average of $96.92. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The company has a market capitalization of $69.94 billion, a price-to-earnings ratio of 24.32, a PEG ratio of 3.61 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business posted $0.87 earnings per share. On average, sell-side analysts predict that Colgate-Palmolive will post 3.74 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.34%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is presently 56.82%.

Analyst Ratings Changes

Several research firms have weighed in on CL. Raymond James reiterated an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday. UBS Group cut their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday. Stifel Nicolaus lowered their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday. TD Cowen cut their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $101.16.

Read Our Latest Research Report on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.